Sign in Subscribe
President of the United States

Trump's Populist Shift: Adopting Democratic Policies to Rally Support

Strategic Insights

— 2 min read

Donald Trump's administration is embracing policies typically associated with progressive Democrats, such as reducing soaring US drug prices, increasing taxes on the wealthy, and stricter enforcement of price-gouging laws. This shift comes as Trump's approval ratings drop due to his handling of the economy and the impact of his tariff plans. The president's move is seen as an attempt to defuse Democratic attacks ahead of the 2026 midterm elections and to recast the Republicans as the party of the working class.

Key Takeaways:

  • Trump's executive order on US drug prices is modeled after a proposal by Democratic Senator Bernie Sanders, which would cut prices by imposing export controls and enforcing anticompetitive behavior in the sector.
  • The president plans to increase the top income tax rate for individuals earning more than $2.5mn a year to 39.7 percent from 37 percent, defying his party's traditional opposition to tax rises.
  • Trump's policies are still disproportionately beneficial to high-income households and harmful to the rest of Americans, making his populism mostly performative, according to critics.
  • The president's populist shift may be an attempt to defuse Democratic attacks ahead of the 2026 midterm elections and recast the Republicans as the party of the working class.
  • Michael Strain, an economic policy analyst at the American Enterprise Institute, notes that the centre of gravity within the Republican party has not shifted on higher taxes, but there is a willingness to go along with policies associated with Democrats.

Statistics:

  • Trump's proposal to increase the top income tax rate for individuals earning more than $2.5mn a year would raise the tax rate to 39.7 percent.
  • The average cost of prescription drugs in the US is among the highest in the world, with Americans paying more than twice as much as the average of 32 other high-income industrialized countries (Source: Commonwealth Fund).
  • Republicans regained their majority in the House of Representatives in 2022 by criticizing the president and his party for giving giant tax cuts to the wealthy while seeking to slash healthcare access for middle- and lower-income Americans (Source: Bloomberg).
  • The Federal Trade Commission has been tasked with taking enforcement action to tackle "anticompetitive" behavior in the pharmaceutical sector.

Sources:

  • Bloomberg: "Trump Orders Pharmaceutical Companies to Cut US Drug Prices"
  • The New York Times: "Trump's Economic Plans Shatter Party's Traditional Opposition to Tax Rises"
  • The Hill: "Sanders Endorses Trump's Plan to Cut US Drug Prices"

Read more